Cardinal Health, Inc. $CAH Shares Sold by LMG Wealth Partners LLC

Key Points

• LMG Wealth Partners LLC reduced its stake in Cardinal Health by 16.7% in Q4, selling 9,736 shares and leaving 48,677 shares valued at about $10.0 million (Cardinal Health is ~1.9% of LMG’s portfolio and its 13th largest holding).
• Cardinal Health beat EPS (reported $3.17 vs. $2.79 est.) and raised FY‑2026 guidance to $10.70–$10.80 while adding $250M in buybacks, but revenue missed estimates and a $184M goodwill impairment hurt GAAP results, producing a mixed investor reaction.
• Analysts maintain a consensus “Moderate Buy” with an average target of $243.67, and the stock is heavily institutionally owned (~87.2%), reflecting continued market interest despite the mixed quarter.

LMG Wealth Partners LLC cut its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 16.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,677 shares of the company's stock after selling 9,736 shares during the period. Cardinal Health accounts for about 1.9% of LMG Wealth Partners LLC's portfolio, making the stock its 13th largest position. LMG Wealth Partners LLC's holdings in Cardinal Health were worth $10,003,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of CAH. Integrated Wealth Concepts LLC lifted its stake in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company's stock valued at $601,000 after acquiring an additional 280 shares during the period. Jones Financial Companies Lllp lifted its stake in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after acquiring an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership acquired a new stake in Cardinal Health during the 2nd quarter valued at approximately $1,935,000. Cerity Partners LLC lifted its stake in Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company's stock valued at $6,792,000 after acquiring an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC lifted its stake in Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company's stock valued at $1,736,000 after acquiring an additional 2,646 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have commented on CAH shares. TD Cowen lifted their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the company a "buy" rating in a research note on Friday. Mizuho lifted their price objective on shares of Cardinal Health from $222.00 to $235.00 and gave the company an "outperform" rating in a research note on Friday, February 6th. Evercore decreased their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an "outperform" rating for the company in a research note on Wednesday, April 8th. JPMorgan Chase & Co. lifted their price objective on shares of Cardinal Health from $209.00 to $243.00 and gave the company a "neutral" rating in a research note on Tuesday, February 10th. Finally, Leerink Partners restated an "outperform" rating and set a $275.00 price objective on shares of Cardinal Health in a research note on Monday, March 9th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $243.67.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an "overweight" rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the "mixed" nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Price Performance

NYSE:CAH opened at $195.13 on Friday. The firm has a market cap of $45.92 billion, a price-to-earnings ratio of 28.08, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53. The company has a 50 day moving average price of $213.73 and a 200-day moving average price of $205.46. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business's quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.79 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend was Wednesday, April 1st. Cardinal Health's payout ratio is presently 29.35%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.